CVM GFI #276 Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 26, 2024
June 25, 2024
6428bf8e-1efb-4173-8319-d9cf1d953630
Related Documents
CVM GFI #253 Current Good Manufacturing Practice for Animal Cells, Tissues, and Cell- and Tissue-Based Products
Guidance DocumentOctober 20, 2022Center for Veterinary Medicine
CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications
Guidance DocumentJune 21, 2024Center for Veterinary Medicine
CVM GFI #254 Donor Eligibility for Animal Cells, Tissues, and Cell- and Tissue-Based Products
Guidance DocumentOctober 20, 2022Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.